How often is xgeva given for giant cell tumor of the bone?

How often is Xgeva (denosumab) given for giant cell tumor of the bone?

For giant cell tumor of the bone, Xgeva (denosumab) is given as a subcutaneous injection once every 4 weeks. [1]

What is the injection schedule (timing) patients follow?

The typical dosing schedule is every 28 days (one dose per month). That means patients receive Xgeva regularly, with each follow-up injection spaced about 4 weeks apart. [1]

Does the schedule change once treatment starts or if the tumor responds?

The provided dosing information supports the ongoing schedule of one injection every 4 weeks for giant cell tumor of the bone. Specific adjustments (like stopping, restarting, or changing the interval) depend on clinical guidance and the patient’s situation. [1]

Why does the “every 4 weeks” schedule matter?

Because the dosing is tied to a fixed interval, missing or delaying doses can affect treatment continuity. Patients are usually expected to keep the 4-week cadence for consistent drug exposure. [1]

Source

1. FDA label for Xgeva (denosumab)